Task force II: Blood pressure measurement and cardiovacular outcome

Blood Pressure Monitoring

Volumn 6, Issue 6, 2001, Pages 355-370

  Staessen, Jan A ^a   Asmar, Roland ^a   De Buyzere, Marc ^a   Imai, Yutaka ^a   Parati, Gianfranco ^a   Shimada, Kazayuki ^a   Stergiou, George ^a   Redón, Josep ^a   Verdecchia, Paolo ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

Ambulatory blood pressure monitoring; Hypertension; Morbidity; Mortality; Prognosis

Indexed keywords

ANTIHYPERTENSIVE AGENT;

ACCURACY; AGING; AMBULATORY MONITORING; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE MONITORING; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CIRCADIAN RHYTHM; CONFERENCE PAPER; CORRELATION ANALYSIS; COST EFFECTIVENESS ANALYSIS; DIABETES MELLITUS; FETUS RISK; HUMAN; MATERNAL HYPERTENSION; OUTCOMES RESEARCH; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; RISK FACTOR; SELF EXAMINATION; SELF MONITORING; STANDARD; TECHNIQUE; WHITE COAT HYPERTENSION; ADULT; AGE; AMBULATORY CARE; CHILD; CONSENSUS DEVELOPMENT; FEMALE; MALE; PATHOPHYSIOLOGY; PHYSIOLOGY; PREGNANCY; SELF CARE; STATISTICS;

ADULT; AGE FACTORS; BLOOD PRESSURE MONITORING, AMBULATORY; CARDIOVASCULAR DISEASES; CHILD; CIRCADIAN RHYTHM; FEMALE; HUMANS; MALE; OFFICE VISITS; PREGNANCY; PROGNOSIS; SELF CARE;

EID: 0035527555     PISSN: 13595237     EISSN: None     Source Type: Journal    
DOI: 10.1097/00126097-200112000-00016     Document Type: Conference Paper

References (174)

1. Normotension and hypertension as defined by 24-h ambulatory blood pressure monitoring
2. An epidemiological approach to ambulatory blood pressure monitoring: The Belgian population study
3. What is a normal blood pressure on ambulatory monitoring?
4. The sixth report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure
5. 1999 World Health Organization-International society of hypertension guidelines for the management of hypertension
6. White coat hypertension. No harm for the heart
7. Ambulatory blood pressure. An independent predictor of prognosis in essential hypertension
8. What is normal blood pressure? Comparison of ambulatory pressure level and variability in patients with normal or abnormal left ventricular geometry
9. Ambulatory blood pressure is superior to clinic blood pressure in predicting treatment-induced regression of left ventricular hypertrophy
10. Prognostic value of ambulatory blood pressure monitoring in refractory hypertension. A prospective study
11. Relationships between changes in left ventricular mass and in clinic and ambulatory blood pressure in response to antihypertensive therapy
12. Reference values for 24-hour ambulatory blood pressure monitoring based on a prognositic criterion. The Ohasama Study
13. Cardiovascular outcome in white-coat versus sustained mild hypertension. A 10-year follow-up study
14. Superiority of 24-hour measurement of blood pressure over clinic values in determining prognosis in hypertension
15. The prognostic value of ambulatory blood pressures
16. Prognostic value of ambulatory blood pressure measurements: Further analyses
17. Predicting cardiovascular risk using conventional vs ambulatory blood pressure in older patients with systolic hypertension
18. Consensus document on non-invasive ambulatory blood pressure monitoring
19. Second international consensus meeting on twenty-four-hour blood pressure measurement: Consensus and conclusions
20. A consensus view on the technique of ambulatory blood pressure monitoring
21. Leuven consensus conference on ambulatory blood pressure monitoring in commemoration of Professor Dr A. Amery († 2 November 1944) 23-25 September 1999
22. Predicting cardiovascular risk using conventional vs ambulatory blood pressure in older patients with systolic hypertension
23. Differential effects of doxazosin on clinic and ambulatory pressure according to age, gender, and presence of white coat hypertension. Results of the HALT study
24. Conventional and ambulatory blond pressure measurement in older patients with isolated systolic hypertension: Baseline observations in the Syst-Eur trial
25. A multicentre trial on the treatment of isolated systolic hypertension in the elderly: Objectives, protocol and organisation
26. Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension
27. Subgroup and per-protocol analysis of the randomized European trial on isolated systolic hypertension in the elderly
28. Adverse effects of nighttime blood pressure on the outcome of lacunar infarct patients
29. Silent and clinically overt stroke in older Japanese subjects with white-coat and sustained hypertension
30. Home versus office monitoring of blood pressure: A European multicentre study of high blood pressure
31. APTH - A trial on ambulatory blood pressure monitoring and treatment of hypertension: Objectives and protocol
32. Treatment of hypertensive patients according to the conventional or ambulatory blood pressure: A progress report on the APTH trial
33. Antihypertensive treatment based on conventional or ambulatory blood pressure measurement. A randomized controlled trial
34. Office versus ambulatory (OvA) recording of blood pressure, a European multicenter study: Inclusion and early follow-up characteristics
35. Effects of blood pressure measurement by the doctor on patient's blood pressure and heart rate
36. Limitations of the difference between clinic and daytime blood pressure as a surrogate measure of the 'white coat' effect
37. Difference between clinic and daytime blood pressure is not a measure of the white coat effect
38. Diagnosis of white coat hypertension by ambulatory blood pressure monitoring
39. The ventricular complex in left ventricular hypertrophy as obtained by unipolar precordial and limb leads
40. Alerting reaction and rise in blood pressure during measurement by physician and nurse
41. Properly defining white coat hypertension
42. White coat effect, blood pressure and mortality in men: Prospective cohort study
43. Response to antihypertensive therapy in older patients with sustained and nonsustained systolic hypertension
44. White-coat hypertension
45. Task Force III: Target organ-damage, morbidity and mortality
46. White-coat hypertension: Not guilty when correctly defined
47. Task Force IV: Clinical use of ambulatory blood pressure monitoring
48. A review of national guidelines on the clinical use of ambulatory blood pressure monitoring
49. Ambulatory blood pressure of adults in Ohasama, Japan
50. The increase in blood pressure with age and body mass index is overestimated by conventional sphygmomanometry
51. Ambulatory and home blood pressure normality in the elderly: Data from the PAMELA population
52. Effect of aging on the prognostic significance of ambulatory systolic, diastolic, and pulse pressure in essential hypertension
53. Editorial review. Isolated systolic hypertension
54. Australian comparative outcome trial of angiotensin-converting enzyme inhibitor- and diuretic-based treatment of hypertension in the elderly (ANBP2): Objectives and protocol
55. Age-related alterations in the circadian pattern of blood pressure
56. Silent cerebrovascular disease in the elderly. Correlation with ambulatory pressure
57. Diurnal blood pressure variations and silent cerebrovascular damage in elderly patients with hypertension
58. The diurnal blood pressure profile. A population study
59. The relationships between left ventricular mass and daytime and night-time blood pressures: A meta-analysis of comparative studies
60. Diurnal blood pressure curve in children and adolescents
61. Nocturnal fall of blood pressure and silent cerebrovascular damage in elderly hypertensive patients: Advanced silent cerebrovascular damage in extreme dippers
62. Predictive value of blood pressure dipping and swinging with regard to vascular disease risk
63. Nocturnal pressure is the true pressure
64. Nocturnal blood pressure fall on ambulatory monitoring in a large international database
65. Factors affecting the nocturnal decrease in blood pressure: A community-based study in Ohasama
66. Optimal definition of daytime and night-time blood pressure
67. Relation between nocturnal decline in blood pressure and mortality. The Ohasama Study
68. Relationship between extreme dippers and orthostatic hypertension in elderly hypertensive patients
69. Altered circadian rhythm of blood pressue and cerebrovascular damage
70. Factors that affect blood pressure variability. A community-based study in Ohasama, Japan
71. Ambulatory blood pressure in the hypertensive population: Patterns and prevalence of hypertensive subforms
72. Prognostic value of ambulatory blood pressure. Current evidence and clinical implications
73. Reversed circadian blood pressure rhythm is associated with occurrences of both fatal and nonfatal vascular events in NIDDM subjects
74. 'Non dipping' related to cardiovascular events in essential hypertensive patients
75. Stroke prognosis and abnormal nocturnal blood pressure falls in older hypertensives
76. Diurnal blood pressure changes and left ventricular mass: Influence of daytime blood pressure
77. Relationship between circadian blood pressure patterns and progression of early carotid atherosclerosis
78. Prognostic significance of blood pressure and heart rate variabilities. The Ohasama Study
79. Dippers and non-dippers
80. Is nocturnal blood pressure dipping reproducible?
81. Plasma epinephrine and norepinephrine concentrations of healthy humans associated with nighttime sleep and morning arousal
82. The relationship between blood pressure and sodium and potassium excretion during the day and at night
83. The early morning rise in blood pressure is related mainly to ambulation
84. Arousal and the circadian rhythm of blood pressure
85. Twenty-four-hour blood pressure is not dependent on endogenous circadian rhythm
86. Blood pressure during siesta: Effect on 24-h ambulatory blood pressue profiles analysis
87. Concurrent morning increase in platelet aggregability and the risk of myocardial infarction and sudden cardiac death
88. Major circadian fluctuations in fibrinolytic factors and possible relevance to time of onset of myocardial infarction, SCD, and stroke
89. Diurnal changes in coronary blood flow in conscious dogs
90. Cardiovascular risk and therapeutic intervention for the early morning surge in blood pressure and heart rate
91. Circadian variation in cardiovascular events
92. Diurnal variation in incidence of stroke
93. Circadian variation in onset of acute ischemic stroke
94. Circadian variation in the frequency of onset of acute myocardial infarction
95. Circadian variation in the frequency of sudden cardiac death
96. Identification of a secondary peak in myocardial infarction onset 11 to 12 hours after awakening: The Cardiac Arrhythmia Suppression Trial (CAST) experience
97. Diurnal variation of and activity during the onset of stroke
98. Continuous vs intermittent blood pressure measurements in estimating 24-hour average blood pressure
99. Advantages and disadvantages of non-invasive ambulatory blood pressure monitoring
100. Influence of short-term blood pressure variability on blood pressure determinations
101. Lack of association between blood pressure variability and left ventricular mass in essential hypertension
102. Prognostic significance of blood pressure variability in essential hypertension
103. Diurnal blood pressure patterns in normotensive and hypertensive children and adolescents
104. Oscillometric twenty-four-hour ambulatory blood pressure values in healthy children and adolescents: A multicenter trial including 1141 subjects
105. Twenty-four-hour ambulatory blood pressure monitoring in young children
106. Ambulatory blood pressure monitoring and interdialytic weight gain in children receiving chronic hemodialysis
107. Ambulatory blood pressure monitoring in children and adolescents: The future
108. Tracking of 24-hour and casual blood pressure: A 1-year follow-up study in adolescents
109. Ambulatory blood pressure monitoring in the pediatric patient
110. Ambulatory blood pressure in schoolchildren
111. 24 Hour blood pressure monitoring in healthy and hypertensive children
112. Efficacy of 24-hour ambulatory blood pressure monitoring in children
113. Evaluation of white coat hypertension in children: Importance of the definitions of normal ambulatory blood pressure and the severity of casual hypertension
114. Ambulatory blood pressure patterns in children and adolescents: Influence of renin-sodium profiles
115. Race and gender influence ambulatory blood pressure patterns of adolescents
116. Ambulatory blood pressure recordings in children and adolescents
117. Ambulatory blood pressure in normotensive and hypertensive subjects: Results from an international database
118. Measurement of blood pressure in children
119. Influence of diurnal blood pressure variations on target organ abnormalities in adolescents with mild essential hypertension
120. Ambulatory blood pressure monitoring in normotensive pregnant women
121. Ambulatory blood pressure monitoring during pregnancy: Establishment of standards of normalcy
122. Prognostic value of 24-hour blood pressure in pregnancy
123. The white coat effect in hypertensive pregnancy: Much ado about nothing?
124. Blood pressure measurement in severe pre-eclampsia
125. Diagnosing gestational hypertension and preeclampsia with the 24-hour mean of blood pressure
126. Blood pressure patterns in normal pregnancy, gestational hypertension, and preeclampsia
127. Can 24-hour ambulatory blood pressure measurement predict the development of hypertension in primigravidae?
128. Blood pressure excess for the early identification of gestational hypertension and preeclampsia
129. Ambulatory blood pressure in pregnancy and fetal growth
130. Birth weight and 24-hour ambulatory blood pressure in nonproteinuric hypertensive pregnancy
131. Automated, ambulatory or conventional blood pressure measurement in pregnancy: Which is the better predictor of severe hypertension?
132. Hypertension in pregnancy: Which method of blood pressure measurement is most predictive of outcome?
133. Ambulatory blood pressure measurement, smoking and abnormalities of glucose and lipid metabolism in essential hypertension
134. Ambulatory blood pressure profile after carotid endarterectomy in patients with ischaemic arterial disease
135. Arterial distensibility and ambulatory blood pressure monitoring in essential hypertension
136. Assessment of arterial distensibility by monitoring the timing of Korotkoff sounds
137. Mesure ambulatoire du temps d'apparition des bruits de korotokoff (intervalle QKD) dans une population normale
138. Ambulatory measurement of the timing of Korotkoff sounds in a group of normal subjects. Influence of age and height
139. Reduction in arterial distensibility in hypertensive patients as evaluated by ambulatory measurement of the QKD interval is correlated with concentric remodeling of the left ventricle
140. The importance of pulsatile components of hypertension in predicting carotid stenosis in older adults
141. Roles of systolic and pulse pressure
142. Risks of untreated and treated isolated systolic hypertension in the elderly: Meta-analysis of outcome trials
143. Pulse pressure and aortic pulse wave are markers of cardiovascular risk in hypertensive populations
144. Is pulse pressure useful in predicting risk for coronary heart disease? The Framingham Heart Study
145. Pulse pressure not mean pressure determines cardiovascular risk in older hypertensive patients
146. Comparison of two angiotensin converting enzyme inibitors with different pharmacokinetics alone or combined with a diuretic on 24-hour blood pressure Levels
147. Home blood pressure monitoring in the elderly
148. Accuracy and reproducibility of 30 devices for self-measurement of arterial blood-pressure
149. Self-monitoring of blood pressure at home: How many measurements are needed?
150. Home self-monitoring of blood pressure: Is fully automated oscillometric technique as good as conventional stethoscopic technique?
151. How to use home blood pressure monitors in clinical practice?
152. State of the market. A review of ambulatory blood pressure monitoring devices
153. Blood pressure measuring devices: Recommendations of the European Society of Hypertension
154. Home blood pressure monitoring. Effect on use of medical services and medical care costs
155. For how many days should blood pressure be measured at home in older patients before steady levels are obtained?
156. Home blood pressure recording
157. Lack of alerting reactions to intermittent cuff inflations during noninvasive blood pressure monitoring
158. Ambulatory blood pressure during antihypertensive therapy guided by conventional pressure
159. Recommendations for the use of home (self) and ambulatory blood pressure monitoring
160. Comparison of clinic, home and ambulatory blood pressure measurement
161. Usefulness of home BP determination in treating borderline hypertension
162. Home blood pressure-measuring devices: A comparative study of accuracy
163. The effects of self-monitoring by patients on the control of hypertension
164. Home self blood pressure measurement in general practice. The SMART Study
165. Home monitoring of blood pressure: Usefulness as a predictor of persistent hypertension
166. Hypertension management in managed care: The role of home blood pressure monitoring
167. Reference values for self-recorded blood pressure. A meta-analysis of summary data
168. The international Database of self-recorded blood pressures in normotensive and untreated hypertensive subjects
169. Ambulatory and home blood pressure normality: The Pamela Study
170. Home blood pressure: Variability, comparison with office readings and proposal for reference values
171. Proposal of reference values for home blood pressure measurement. Prognostic criteria based on a prospective observation of the general population in Ohasama, Japan
172. The Tecumseh blood pressure study. Normative data on blood pressure self-determination
173. Home blood pressure measurement has a stronger predictive power for mortality than does screening blood pressure measurement: A population-based observation in Ohasama, Japan
174. Antihypertensive treatment based on home or office blood pressure measurement: Protocol of the randomized controlled THOP trial